Skip to Content

VESALIUS-CV: Evolocumab in High-Risk Primary Prevention

2026 m. liepos 17 d. pagal
Rohan Parikh

Start writing here...

yra News
Tobacco, Gutka and Your Heart: What Every User Should Know